Nutiani HN001™

Supported by more than 27 human clinical studies, Nutiani HN001™ (formerly LactoB HN001™) is a strain of Lactobacillus rhamnosus that works to improve digestive health by reducing gut discomfort and constipation as well as potentially reducing the risk of allergens and infections. It has been shown to reduce inflammation associated with increased cytokine interleukin 6 levels, enhance magnesium and calcium retention to support bone mineral density, and improve immune protection. Two studies in particular show Nutiani HN001™ may aid in two marketable areas: Support for women's health by potentially reducing the risk of post-natal depression Reducing the risk of developing eczema and mitigating the severity of eczema in young children Researched Benefits include: Supports gut health integrity and internal barrier function Reduces the risk of post-natal depression Reduces risk of eczema May improve immune protection Improves magnesium and calcium retention to support bone mineral density May help reduce inflammation associated with increased cytokine interleukin 6 levels Nutiani HN001™ is manufactured in a proprietary method to increase shelf-life stability with a reduced die-off rate. The stability of Nutiani HN001™ allows it to be formulated into capsules, ice cream, yogurts, certain foods, high fiber juices, and confectionaries with a minimum recommended dosage of 22 billion CFU/g (40mg). The variety of applications and its FDA GRAS status gives manufacturers flexibility with product formulation and marketability.